Next Article in Journal
EUS-Guided Versus Percutaneous Celiac Neurolysis for the Management of Intractable Pain Due to Unresectable Pancreatic Cancer: A Randomized Clinical Trial
Next Article in Special Issue
The Value of Morphometric Measurements in Risk Assessment for Donor-Site Complications after Microsurgical Breast Reconstruction
Previous Article in Journal
Using Machine Learning to Predict ICU Transfer in Hospitalized COVID-19 Patients
Previous Article in Special Issue
Response of Breast Cancer Cells to PARP Inhibitors Is Independent of BRCA Status
 
 

Order Article Reprints

Journal: J. Clin. Med., 2020
Volume: 9
Number: 1663

Article: Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial
Authors: by Gabriel Rinnerthaler, Simon Peter Gampenrieder, Hubert Hackl, Markus Steiner, Claudia Monzo-Fuentes, Thomas Melchardt, Teresa Magnes, Florian Huemer, Theresa Westphal, Clemens Hufnagl, Cornelia Hauser-Kronberger, Alexander Egle and Richard Greil
Link: https://www.mdpi.com/2077-0383/9/6/1663

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Shipping Address

Billing Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop